about
Orthobunyavirus ultrastructure and the curious tripodal glycoprotein spikeZika virus in the Americas: Early epidemiological and genetic findingsMolecular mechanism of lipopeptide presentation by CD1aNative functionality and therapeutic targeting of arenaviral glycoproteinsStructural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2Crystal Structure and Carbohydrate Analysis of Nipah Virus Attachment Glycoprotein: a Template for Antiviral and Vaccine DesignCarbohydrate and domain architecture of an immature antibody glycoform exhibiting enhanced effector functionsUnusual Molecular Architecture of the Machupo Virus Attachment GlycoproteinStructural Plasticity of Eph Receptor A4 Facilitates Cross-Class Ephrin SignalingDimeric Architecture of the Hendra Virus Attachment Glycoprotein: Evidence for a Conserved Mode of AssemblyChemical and Structural Analysis of an Antibody Folding Intermediate Trapped during Glycan BiosynthesisSelective Deactivation of Serum IgG: A General Strategy for the Enhancement of Monoclonal Antibody Receptor InteractionsEngineering Hydrophobic Protein–Carbohydrate Interactions to Fine-Tune Monoclonal AntibodiesCrystal structure of sialylated IgG Fc: Implications for the mechanism of intravenous immunoglobulin therapyCrystal Structure of Venezuelan Hemorrhagic Fever Virus Fusion Glycoprotein Reveals a Class 1 Postfusion Architecture with Extensive GlycosylationImmune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodiesGlycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodiesStructural plasticity of the Semliki Forest virus glycome upon interspecies transmission.Human antibody pieces together the puzzle of the trimeric Lassa virus surface antigen.Structure of a phleboviral envelope glycoprotein reveals a consolidated model of membrane fusion.Uukuniemi Phlebovirus assembly and secretion leave a functional imprint on the virion glycomeShared paramyxoviral glycoprotein architecture is adapted for diverse attachment strategiesEvidence for henipavirus spillover into human populations in Africa.Timing of galectin-1 exposure differentially modulates Nipah virus entry and syncytium formation in endothelial cells.Averaging of viral envelope glycoprotein spikes from electron cryotomography reconstructions using JsubtomoMolecular recognition of human ephrinB2 cell surface receptor by an emergent African henipavirus.Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection.Acidic pH-Induced Conformations and LAMP1 Binding of the Lassa Virus Glycoprotein Spike.Emerging Paramyxoviruses: Receptor Tropism and Zoonotic PotentialDevelopment of a Cost-effective Ovine Polyclonal Antibody-Based Product, EBOTAb, to Treat Ebola Virus Infection.The evolutionary dynamics of influenza A virus adaptation to mammalian hosts.Cells under siege: viral glycoprotein interactions at the cell surface.Structural transitions of the conserved and metastable hantaviral glycoprotein envelope.Idiosyncratic Mòjiāng virus attachment glycoprotein directs a host-cell entry pathway distinct from genetically related henipaviruses.Convergent immunological solutions to Argentine hemorrhagic fever virus neutralization.Determination of N-linked Glycosylation in Viral Glycoproteins by Negative Ion Mass Spectrometry and Ion Mobility.Effect of Live Poultry Market Interventions on Influenza A(H7N9) Virus, Guangdong, China.Cross-Reactive and Cross-Neutralizing Activity of Human Mumps Antibodies Against a Novel Mumps Virus From Bats.The Evolution and Transmission of Epidemic GII.17 Noroviruses.A10 The evolution and molecular epidemiology of epidemic GII.17 noroviruses.
P50
Q21131378-40F1B2EF-C934-423E-9194-3700EDD41C3EQ23649767-B5A6A625-2817-4CF9-8BED-AD7AE1C48975Q24296184-6AEB4AE1-5DAC-4721-AEB7-DA3A5821FD63Q26827679-0EDA2CE1-7163-47FD-931C-F7122D6B17D9Q27650639-ED81AB5E-A9B0-4077-B31B-D21648DD1D6AQ27652284-511D8EDA-127A-4C36-AC65-155FB78F3DA8Q27653897-267015D0-D31D-4800-B419-0BABDF8DDE26Q27655727-B0B224C8-CFA2-40FC-9C87-9DFCEF450FA1Q27657815-9109D9C6-964B-4429-9008-1BD743D152B4Q27660451-90EC4061-A1CC-41B4-94DA-EFD250056F9FQ27673777-B825C437-7CE1-4B8F-861F-FD6D54586556Q27678384-86B024B3-A45E-446E-B88E-25935AC1F3DAQ27678524-5CE2A36D-A48B-4C3D-9E97-B8650DD7F4FCQ27679470-E403F9D3-5695-4750-B7CB-48404AB75FA8Q27679988-D58858FC-E5EE-4C9B-8314-4BC88DDC4A7CQ28069362-C283894C-F571-4056-A618-A3722F922B5AQ28263932-57E5F22A-56AB-4EBE-BF1D-7D5ED1422F01Q30358358-985CE618-0C83-4D2E-8F1B-88A94965DDBCQ33365688-AE070EED-3056-44E5-9DC6-B594F318E8EAQ33433292-1D7F89A3-D8D2-4B99-91A6-42C12E5C2F7DQ34059387-22F7A2C7-B151-4C05-91FC-64EB7BA39878Q34139647-170B64E9-6E06-4267-9145-6EE80F437EC1Q34541512-E8EC1771-5A78-4E0A-AF5F-D8842682D999Q35076790-4DAB8F15-CF15-41A4-A877-F0E192D1938AQ35372170-EE4AA129-52F9-4430-81C4-DFFEAA659478Q35567105-D5A3DBE1-F191-49FD-84B2-A58E1D23C3ADQ35847032-23EDCEC8-888E-4D2F-8B4D-A2849B7F2192Q35915630-1E493B88-CF39-41E5-A786-C43F037902D1Q35935805-2FB9537F-71F7-4AFD-B801-7F2D566A1CA4Q36654562-C01F1D23-29B6-419F-A76B-D166D136466BQ36918060-EDA0E261-B942-424F-9167-A25BFADA976BQ37858167-83CD9BF2-4E5B-4843-945A-42BE3B41E10EQ38611186-13C9B12D-A224-461A-9CCA-7FE7890F99F6Q38682844-73A81244-FAC2-4DC6-8816-AE5E6EECC950Q38718346-E69220BD-131C-4BE5-8EE3-59F5579EDACAQ38853560-8CF2AD94-51E4-4F65-BB35-C902510EBD6AQ39169020-A4F27BE4-4A27-4F80-91D1-26323229D138Q39218193-142A2701-545F-4F6D-B980-3B12AF5CD399Q39647088-C9967A97-82E7-43CF-89A7-6A44D1171973Q40068648-0794155D-4EB0-4D2D-A05D-3D014DADF36B
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Thomas A Bowden
@nl
Thomas A Bowden
@sl
Thomas A. Bowden
@en
Thomas A. Bowden
@es
type
label
Thomas A Bowden
@nl
Thomas A Bowden
@sl
Thomas A. Bowden
@en
Thomas A. Bowden
@es
prefLabel
Thomas A Bowden
@nl
Thomas A Bowden
@sl
Thomas A. Bowden
@en
Thomas A. Bowden
@es
P106
P1153
24340921000
P21
P31
P496
0000-0002-8066-8785